PAS
FOLD

Point72 Asia (Singapore)’s Amicus Therapeutics FOLD Stock Holding History

Point72 Asia (Singapore)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-211
Closed -$1.21K – 1023
2025
Q2 		$1.21K Sell
211
-11,207
-98% -$72.3K ﹤0.01% 832
2025
Q1 		$93.2K Buy
+11,418
New +$106K 0.02% 427
2024
Q4 		– Sell
-5,194
Closed -$55.5K – 994
2024
Q3 		$55.5K Buy
+5,194
New +$56.6K 0.01% 671
2024
Q2 		– Sell
-29,469
Closed -$347K – 1182
2024
Q1 		$347K Buy
+29,469
New +$377K 0.09% 245

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Point72 Asia (Singapore)'s FOLD Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Amicus Therapeutics (FOLD) in Q3 2025, closing a stake of 211 shares — an estimated $1.21K sold.

Point72 Asia (Singapore) first reported a position in FOLD in Q1 2024 and held it in 4 quarters. The position peaked at $347K in Q1 2024. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Amicus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 211 Amicus Therapeutics shares in Q3 2025, an estimated $1.21K.
  • Point72 Asia (Singapore) first reported a position in Amicus Therapeutics in Q1 2024 and held it in 4 quarters.
  • Point72 Asia (Singapore)'s Amicus Therapeutics position peaked at $347K in Q1 2024.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.